APA (7th ed.) Citation
(2026). Successful Treatment of IL‐23 Inhibitor–Refractory Nail Psoriasis With Deucravacitinib: A Case Report. JEADV Clinical Practice.
Chicago Style (17th ed.) Citation
"Successful Treatment of IL‐23 Inhibitor–Refractory Nail Psoriasis With Deucravacitinib: A Case Report." JEADV Clinical Practice 2026.
MLA (9th ed.) Citation
"Successful Treatment of IL‐23 Inhibitor–Refractory Nail Psoriasis With Deucravacitinib: A Case Report." JEADV Clinical Practice, 2026.
Warning: These citations may not always be 100% accurate.